Mark Mccamish is a eficient expert, working in Forty Seven as a President and Chief Executive Officer since 2017. This expert has earned professional experience in more than ten positions at various companies. Mark Mccamish went to the University of California, Los Angeles and got education there from 1983 to 1985. San Francisco, California is the city, where this professional was known to be living. The person's phone number and email are accessed through SoftwareOfficial on demand.
Name variants:
Marc Mccamish,
Marcus Mccamish,
Markus Mccamish,
Marquis Mccamish,
Mark Mccamish
Last updated Jun 04, 2024
Contact Information
Last Update
Jun 30, 2022
Email
ma**@facetbiotech.com, ma**@sandoz.com, ma**@gmail.com
Location
San Francisco, CA
Company
Forty Seven
Workplace
President and Chief Executive Officer
Work History
Global Head Biopharmaceutical Development
Sandoz, a division of Novartis, is a leader in developing and launching follow on biologics or biosimilars. This position is responsible for leading global efforts in developing multiple fol...
Jul 2009 — Apr 2017
Vice President and Chief Medical Officer
He was responsible for using Perlegen’s pharmacogenomics technology to develop genetically targeted therapeutics – to deliver on the promise of pharmacogenomic technology including developme...
2003 — 2007
Medical Director
Illinois
While at Abbott, his responsibilities were broad and included: worldwide clinical research, design and development of new products, oversight of medical affairs (product complaints, potentia...
1990 — 1997
Education
Jan 1, 1983 — 1985
Jan 1, 1977 — 1980
Jan 1, 1973 — Dec 31, 1977
Occupations
Executive
Senior Vice President
Surgeon-General
Vice President
Chief Executive
Health Services Director
Health Services Manager
Skills
Clinical Development
Drug Development
Clinical Trials
Oncology
Immunology
Pharmaceutical Industry
Biotechnology
Regulatory Affairs
Clinical Research
Fda
Biopharmaceuticals
Cro
Biologics
Medical Affairs
Medical Devices
Nephrology
Therapeutic Areas
Clinical Operations
Commercialization
Drug Discovery
Diabetes
Medicine
Gcp
Gastroenterology
Endocrinology
Regulatory Submissions
Clinical Pharmacology
Hematology
Ind